Substituted aniline derivatives useful as histamine H3 antagonists

Details for Australian Patent Application No. 2006331850 (hide)

Owner Schering Corporation

Inventors Tom, Wing C.; McCormick, Kevin D.; Mutahi, Mwangi W.; Solomon, Daniel M.; Aslanian, Robert G.; De Lera Ruiz, Manuel; Berlin, Michael Y.

Agent Griffith Hack

Pub. Number AU-A-2006331850

PCT Pub. Number WO2007/075688

Priority 60/752,637 21.12.05 US

Filing date 19 December 2006

Wipo publication date 5 July 2007

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/075688 Priority application(s): WO2007/075688

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331857-Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder

2006331849-Methods for assessing the proinflammatory immune health of an individual